Clinical and laboratory findings and PCR results in severe and non-severe COVID19 patients based on CURB-65 and WHO severity indices

Table 8 Baseline characteristics of COVID-19 patients based on CURB-65 classification

Variables	CURB-65 score ≤ 1 (n = 130)	CURB-65 score ≥ 2 (n = 28)	P value
Age. Mean (SD)	50.3 (13.5)	70.1 (12.4)	< 0.001
Initial vital sign. Mean (SD)
RR	19.1 (2.8)	19.3 (2.8)	0.785
Temp	37.0 (0.8)	37.3 (1.1)	0.060
PR	100.0 (17.7)	95.3 (25.7)	0.247
Sys BP	129.0 (20.2)	134.2 (20.1)	0.218
Dias BP	79.8 (11.8)	76.7 (16.2)	0.255
O2 SAT	91.9 (5.3)	87.6 (9.3)	< 0.001
Symptoms. no (%)
Cough	96 (73.8)	16 (57.1)	0.078
Fever	67 (51.5)	13 (46.4)	0.624
Chill	50 (38.5)	9 (32.1)	0.531
Dyspnea	73 (56.2)	16 (57.1)	0.924
Sore throat	28 (21.5)	2 (7.1)	0.078
Headache	44 (33.8)	5 (17.9)	0.097
Dizziness	33 (25.4)	3 (10.7)	0.093
Weakness	63 (45.8)	15 (53.6)	0.624
Muscular pain	57 (43.8)	15 (53.6)	0.349
Diarrhea	23 (17.7)	3 (10.7)	0.366
Abdominal pain	13 (10.0)	1 (3.6)	0.278
Anorexia	61 (46.9)	11 (39.3)	0.462
Nausea	45 (34.6)	6 (21.4)	0.176
Vomiting	25 (19.2)	4 (14.3)	0.540
Comorbidities. no (%)
Diabetes	23 (17.7)	12 (42.9)	0.004
Hyperlipidemia	6 (4.6)	4 (14.3)	0.057
Hypertension	24 (18.5)	13 (46.4)	0.002
Chronic heart disease	14 (10.8)	10 (35.7)	< 0.001
Chronic kidney disease	0 (0.0)	1 (0.9)	0.501
Asthma	5 (3.8)	4 (14.3)	0.031
COPD	0 (0.0)	0 (0.0)	–
Cirrhosis	0 (0.0)	0 (0.0)	–
Autoimmune disease	1 (0.8)	0 (0.0)	0.642
History of malignancy	1 (0.8)	0 (0.0)	0.642
Recent chemoradiotherapy	1 (0.8)	0 (0.0)	0.642
Current steroid use	1 (0.8)	0 (0.0)	0.642
Immunosuppressant drug use	1 (0.8)	0 (0.0)	0.642

RR respiratory rate, Temp temperature, PR pulse rate, Sys BP systolic blood pressure, Dias BP diastolic blood pressure, O2 Sat O2 saturation, CHD chronic heart disease, CKD chronic kidney disease, COPD chronic obstructive pulmonary disease

ISSN: 1743-422X